As of 2026-10-12, the Relative Valuation of Theraclion SA (ALTHE.PA) is (1.95) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.67 EUR, the upside of Theraclion SA based on Relative Valuation is -391.4%.
The range of the Relative Valuation is (1.81) - (1.97) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 24.0x | 22.4x |
| Forward P/E multiples | 18.6x - 21.3x | 19.9x |
| Fair Price | (1.81) - (1.97) | (1.95) |
| Upside | -369.8% - -394.1% | -391.4% |
| Date | P/E |
| 2026-10-09 | -7.25 |
| 2026-10-08 | -6.82 |
| 2026-10-07 | -6.95 |
| 2026-10-06 | -7.03 |
| 2026-10-05 | -7.12 |
| 2026-10-02 | -7.16 |
| 2026-10-01 | -7.36 |
| 2026-09-30 | -7.51 |
| 2026-09-29 | -7.57 |
| 2026-09-28 | -7.76 |
| 2026-09-25 | -8.11 |
| 2026-09-24 | -7.38 |
| 2026-09-23 | -7.41 |
| 2026-09-22 | -7.62 |
| 2026-09-21 | -7.66 |
| 2026-09-18 | -7.68 |
| 2026-09-17 | -7.34 |
| 2026-09-16 | -7.17 |
| 2026-09-15 | -6.92 |
| 2026-09-14 | -6.86 |
| 2026-09-11 | -7.05 |
| 2026-09-10 | -7.42 |
| 2026-09-09 | -7.57 |
| 2026-09-08 | -7.41 |
| 2026-09-07 | -7.51 |
| 2026-09-04 | -7.92 |
| 2026-09-03 | -7.92 |
| 2026-09-02 | -7.28 |
| 2026-09-01 | -8.33 |
| 2026-08-31 | -8.11 |
| 2026-08-28 | -7.23 |
| 2026-08-27 | -6.77 |
| 2026-08-26 | -6.98 |
| 2026-08-25 | -6.86 |
| 2026-08-24 | -6.92 |
| 2026-08-21 | -7.00 |
| 2026-08-20 | -7.12 |
| 2026-08-19 | -7.09 |
| 2026-08-18 | -6.92 |
| 2026-08-17 | -7.15 |
| 2026-08-14 | -7.23 |
| 2026-08-13 | -7.05 |
| 2026-08-12 | -6.72 |
| 2026-08-11 | -6.81 |
| 2026-08-10 | -6.43 |
| 2026-08-07 | -6.54 |
| 2026-08-06 | -6.54 |
| 2026-08-05 | -6.60 |
| 2026-08-04 | -6.83 |
| 2026-08-03 | -6.35 |